What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Disease
- Acquired immunodeficiency syndrome
David Mabey mainly focuses on Chlamydia trachomatis, Trachoma, Immunology, Sexually transmitted disease and Environmental health.
His Chlamydia trachomatis research is multidisciplinary, incorporating elements of Eye disease, Chlamydia and Disease.
The various areas that David Mabey examines in his Trachoma study include Transmission, Internal medicine, Epidemiology and Surgery.
His biological study spans a wide range of topics, including Odds ratio and Risk factor.
His work deals with themes such as Condom, Syphilis, Incidence and Pediatrics, which intersect with Sexually transmitted disease.
David Mabey has researched Environmental health in several fields, including Developing country, Psychological intervention, Public health and Prevalence.
His most cited work include:
- Neglected tropical diseases (676 citations)
- Diagnostics for the developing world. (653 citations)
- Rapid tests for sexually transmitted infections (STIs) : the way forward (381 citations)
What are the main themes of his work throughout his whole career to date?
David Mabey focuses on Trachoma, Chlamydia trachomatis, Immunology, Azithromycin and Internal medicine.
His Trachoma research incorporates themes from Epidemiology, Surgery, Disease and Environmental health.
In his work, Gonorrhea is strongly intertwined with Chlamydia, which is a subfield of Chlamydia trachomatis.
His study in Immunology is interdisciplinary in nature, drawing from both Acquired immunodeficiency syndrome and Sexually transmitted disease.
While the research belongs to areas of Acquired immunodeficiency syndrome, David Mabey spends his time largely on the problem of Syphilis, intersecting his research to questions surrounding Family medicine.
His studies in Sexually transmitted disease integrate themes in fields like Gynecology and Pediatrics.
He most often published in these fields:
- Trachoma (35.90%)
- Chlamydia trachomatis (30.77%)
- Immunology (25.81%)
What were the highlights of his more recent work (between 2014-2021)?
- Trachoma (35.90%)
- Chlamydia trachomatis (30.77%)
- Azithromycin (16.92%)
In recent papers he was focusing on the following fields of study:
His main research concerns Trachoma, Chlamydia trachomatis, Azithromycin, Internal medicine and Immunology.
His Trachoma research is multidisciplinary, relying on both Mass drug administration, Public health, Surgery and Disease.
His Chlamydia trachomatis research is multidisciplinary, incorporating perspectives in Transmission, Chlamydia, Odds ratio and Epidemiology.
His Azithromycin course of study focuses on Antibiotic resistance and Genotype.
His work in Internal medicine tackles topics such as Serology which are related to areas like Syphilis.
His Immunology study frequently draws parallels with other fields, such as Cohort.
Between 2014 and 2021, his most popular works were:
- Sexually transmitted infections: challenges ahead (268 citations)
- Mass Treatment with Single-Dose Azithromycin for Yaws (77 citations)
- Comprehensive global genome dynamics of Chlamydia trachomatis show ancient diversification followed by contemporary mixing and recent lineage expansion (57 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Disease
- Acquired immunodeficiency syndrome
His primary scientific interests are in Trachoma, Internal medicine, Chlamydia trachomatis, Azithromycin and Serology.
His research integrates issues of Treponema, Seroprevalence, Immunology and Virology in his study of Trachoma.
As a member of one scientific family, he mostly works in the field of Immunology, focusing on Cohort and, on occasion, Cohort study and Pathogenesis.
His Internal medicine study combines topics from a wide range of disciplines, such as Surgery, Cross-sectional study, Transmission, Rapid plasma reagin and Mass drug administration.
His Chlamydia trachomatis research is multidisciplinary, incorporating perspectives in Chlamydia, Immune system, Pathology and Environmental health.
His Azithromycin research is multidisciplinary, incorporating elements of Antibiotic resistance, Parasitology and Staphylococcus aureus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
